MENU
+Compare
INVA
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$18.58
Change
+$0.13 (+0.70%)
Capitalization
1.16B

INVA Innoviva Forecast, Technical & Fundamental Analysis

a biopharmaceutical company

Industry Biotechnology
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for INVA with price predictions
Jan 08, 2025

INVA in +0.98% Uptrend, advancing for three consecutive days on January 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INVA advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INVA entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.740) is normal, around the industry mean (14.746). P/E Ratio (23.225) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). INVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (3.609) is also within normal values, averaging (264.084).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INVA is expected to report earnings to rise 1,500.00% to 31 cents per share on February 05

Innoviva INVA Stock Earnings Reports
Q4'24
Est.
$0.32
Q3'24
Missed
by $0.25
Q2'24
Missed
by $0.79
Q1'24
Beat
by $0.28
Q4'23
Beat
by $0.53
The last earnings report on November 06 showed earnings per share of 1 cents, missing the estimate of 27 cents. With 606.50K shares outstanding, the current market capitalization sits at 1.16B.
A.I.Advisor
published Dividends

INVA paid dividends on September 30, 2015

Innoviva INVA Stock Dividends
А dividend of $0.25 per share was paid with a record date of September 30, 2015, and an ex-dividend date of September 08, 2015. Read more...
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFEPX20.430.19
+0.94%
NAA Large Core P
IEDZX13.340.07
+0.53%
Voya Large Cap Value R6
ACARX32.90N/A
N/A
Alger Capital Appreciation Instl R
APHNX15.77N/A
N/A
Artisan Select Equity Institutional
EAASX35.54-0.02
-0.06%
Eaton Vance Atlanta Capital SMID-Cap A

INVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with SGMO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+0.70%
SGMO - INVA
40%
Loosely correlated
-0.91%
CMPX - INVA
38%
Loosely correlated
+4.00%
CRSP - INVA
35%
Loosely correlated
+0.57%
TSVT - INVA
35%
Loosely correlated
+6.97%
REGN - INVA
35%
Loosely correlated
-1.68%
More